Overview of Ringworm in Children

Ringworm, medically termed tinea corporis, is a common superficial fungal infection of the skin caused by dermatophytes (fungi) and represents one of the most frequent infectious skin conditions in children. The condition affects children of all ages but is most common in school-age children. The term "ringworm" is descriptive of the characteristic ring-shaped lesion with central clearing and peripheral erythema, though the condition has no relationship to parasitic worms. Tinea corporis affects approximately 1-5% of children and is easily transmitted between individuals through direct contact, contaminated surfaces, or contact with infected animals. While ringworm is generally not serious, it is contagious and can spread rapidly in childcare and school settings. Prompt diagnosis and treatment prevent spread and help affected children return to normal activities quickly.

Epidemiology and Etiologic Agents

Tinea corporis is caused by dermatophytic fungi that colonize the stratum corneum. The most common causative organisms include Trichophyton rubrum, Trichophyton mentagrophytes, and Microsporum canis. Trichophyton rubrum is anthropophilic (prefers human hosts) and the most common cause of tinea corporis globally. Microsporum canis is zoophilic, transmitted from infected cats or dogs. The incidence of tinea corporis varies geographically, with higher rates in warm, humid climates. Transmission occurs through direct contact with infected persons or contaminated materials including towels, bedding, and fomites. Contact with infected animals, particularly kittens and puppies, represents a significant transmission source. Ringworm thrives in warm, moist, occluded environments, predisposing areas with friction or maceration. Risk factors include swimming pool or locker room exposure, poor hygiene in crowded conditions, and immunosuppression. Atopy and integrity of skin barrier may affect susceptibility.

Clinical Presentation

Tinea corporis classically presents as an annular (ring-shaped) lesion with a raised, erythematous, scaly border and central clearing of normal-appearing or slightly hypopigmented skin. The lesions are typically pruritic and may show vesiculation at the active border. Multiple lesions are common, often arranged in clusters or linear patterns following trauma or areas of friction. Lesions most commonly affect exposed areas including the extremities, trunk, and face. The scalp (tinea capitis), nails (onychomycosis), and intertriginous areas represent distinct clinical presentations with different management. Some children develop vesicular or inflammatory forms of tinea corporis. In tinea gladiatorum (seen in wrestlers), lesions may develop on contact-prone areas. In tinea pedis (athlete's foot), the intertriginous spaces of the toes are typically involved with maceration, scaling, and pruritus. Lesions typically expand centrifugally (outward from the center) over days to weeks without treatment.

Diagnosis and Identification

Diagnosis is primarily clinical based on characteristic ring-shaped lesions. Confirmation can be obtained through direct microscopic examination of scale using potassium hydroxide (KOH) preparation, which disrupts cellular material revealing fungal elements. Fungal culture on Sabouraud dextrose agar or dermatophyte test medium allows identification of the specific fungal organism, which may guide management and help identify potential animal sources. Wood's lamp examination (365 nm) may aid diagnosis by showing fluorescence of certain organisms (though most dermatophytes do not fluoresce significantly). Dermoscopy may show characteristic features including scales and vessel patterns. In cases with unclear diagnosis or treatment failure, biopsy and histopathology can confirm fungal infection. The combination of clinical appearance and KOH preparation typically suffices for diagnosis in most cases without need for culture.

Management and Treatment

Topical antifungal therapy represents first-line treatment for most tinea corporis in children. Azoles (clotrimazole, miconazole, ketoconazole) and allylamines (terbinafine) are effective topical agents. These should be applied to the affected area and 1-2 cm surrounding normal skin, once or twice daily for 2-4 weeks. Terbinafine typically requires 2-4 weeks of therapy, while azoles may require 4-6 weeks. Oral antifungal therapy is reserved for extensive disease, failure of topical therapy, or infections of the scalp or nails. Griseofulvin has traditionally been used for systemic therapy but is less frequently prescribed currently. Oral terbinafine and itraconazole offer advantages of shorter treatment duration and improved efficacy for certain organisms. Treatment should continue until clinical resolution is evident plus an additional 1-2 weeks to ensure complete eradication. The child should be instructed to complete the full prescribed course even if lesions improve earlier.

Prevention and Control Measures

Prevention of tinea corporis centers on reducing exposure and transmission. Children should avoid sharing towels, bathrobes, bedding, or personal hygiene items with infected individuals. Swimming pools and locker rooms should be avoided until treatment has been initiated. Careful attention to personal hygiene including thorough drying of skin folds helps prevent fungal growth. Contact with infected animals should be minimized until the animal has received treatment. Anyone with suspected fungal infection in the household should be evaluated and treated to prevent ongoing transmission. Children with tinea corporis can typically return to school 24-48 hours after initiating treatment if lesions can be covered with clothing or bandages. Close contacts including family members should be examined for evidence of infection. Teachers and school staff should be informed of proper infection control measures, though exclusion from school once treatment has begun is not typically necessary.

Frequently Asked Questions

How did my child get ringworm? Ringworm spreads through direct contact with infected persons or animals, or through contaminated surfaces like towels or gym equipment.

Is this serious? Tinea corporis is not serious and responds well to treatment. Without treatment, lesions may spread and persist for months.

Can my child go to school? Yes, with treatment. The child can return to school within 24-48 hours after starting antifungal therapy if lesions are covered.

Will this scar the skin? No. Tinea corporis resolves without scarring when appropriately treated. Hypopigmentation may persist temporarily after resolution.

Why did treatment fail? Common reasons include incomplete adherence, inadequate duration of treatment, or infection with treatment-resistant organisms requiring oral therapy.

References

  1. Paller AS, Mancini AJ. Hurwitz Clinical Pediatric Dermatology. 5th ed. Elsevier; 2016.
  2. Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 6th ed. Elsevier; 2016.
  3. Hay RJ. Fungal infections of the skin and nails: Annals of the New York Academy of Sciences. Ann N Y Acad Sci. 2000;917:163-168.
  4. Singal A, Khanna D. Dermatophytosis across India: prevalence study. Indian J Dermatol. 2011;56(5):527-531.
  5. Elewski BE. Tinea corporis: a review. J Drugs Dermatol. 2010;9(10):1225-1230.
  6. Crawford F, Hart R,Bbe K, et al. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev. 2007;(3):CD001434.
  7. Gupta AK, Ryder JE, Cooper EA, et al. Prophylactic benefits of itraconazole for tinea corporis and tinea pedis infections in athletes. Cutis. 2003;72(5):380-386.
  8. Sobera JO, Elewski BE. Fungal diseases. In: Arndt KA, et al., eds. Cutaneous Medicine and Surgery. 3rd ed. WB Saunders; 1995.